Moderna | MRNA - Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Moderna USD 597M 6M 2026-06
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 32.13M 1.04M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Qiagen NV USD 1.63B 19.45M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tilray USD 268.59M 3.82M 2025-09
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 172.8M 9.49M 2026-06